Refining Risk Stratification in Pulmonary Embolism
نویسندگان
چکیده
منابع مشابه
Risk-stratification in normotensive acute pulmonary embolism
In the Netherlands, 10,000 to 12,500 patients per year are diagnosed with acute pulmonary embolism (PE) [1]. The large majority of these patients are normotensive. Just recently, the European Society of Cardiology (ESC) published an update of their guideline on the diagnosis and management of acute PE [2]. Compared with the previous version of 2008, special emphasis was given to risk stratifica...
متن کاملECG for risk stratification in patients with pulmonary embolism.
sampling and separation of serum from blood cells. We agree with M. John and K. Jung that we must be aware of pre-analytical problems when analysing the circulating matrix metalloproteinase (MMP)-9 and tissue inhibitor of metalloproteinase (TIMP)-1 levels. However, we used only serum samples in our study because we usually use serum samples for clinical examinations in our hospital. Therefore, ...
متن کاملRisk stratification in pulmonary embolism: an algorithmic tool approach.
It is with much interest we read the article by Jiménez et al and the accompanying editorial Focusing investigation on patients with symptomatic pulmonary thromboembolism (PTE) but who are normotensive at presentation, it reminds us that work still needs to be undertaken for the 95% of patients (including the 15% with submassive disease) who remain haemodynamically stable and excluded from thro...
متن کاملRisk stratification in pulmonary embolism based on biomarkers and echocardiography.
Since the initial observation that elevated cardiac troponin T levels are closely associated with mortality in acute pulmonary embolism,1 several reports have confirmed the prognostic role of cardiac troponins in this setting.2,3 More recently, yet another group of biomarkers, the natriuretic peptides B-type natriuretic peptide (BNP) and N-terminal-pro-B-type natriuretic peptide (NT-proBNP), em...
متن کاملPulmonary embolism risk stratification: where are we heading?
Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Chest
سال: 2020
ISSN: 0012-3692
DOI: 10.1016/j.chest.2020.04.001